Atypical Femoral Fractures: A Teaching Perspective

被引:19
作者
Khan, Aliya A. [1 ]
Leslie, William D. [2 ]
Lentle, Brian [3 ]
Iles, Sian [4 ]
Kaiser, Stephanie M. [5 ]
Frame, Heather [6 ,7 ]
Burrell, Steven [4 ]
Cheung, Angela M. [8 ]
机构
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] Univ Manitoba, Dept Med, Winnipeg, MB, Canada
[3] Univ British Columbia, Dept Radiol, Womens Hlth Ctr, Vancouver, BC, Canada
[4] Dalhousie Univ, Dept Radiol & Nucl Med, Halifax, NS, Canada
[5] Dalhousie Univ, Dept Med, Halifax, NS, Canada
[6] Univ Manitoba, Assiniboine Clin, Winnipeg, MB, Canada
[7] Univ Manitoba, Fac Med, Dept Obstet & Gynecol, Mature Womens Ctr, Winnipeg, MB, Canada
[8] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada
来源
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES | 2015年 / 66卷 / 02期
关键词
Atypical femoral fractures; Imaging; Bone scan; Computed tomography; Bisphosphonates; SUPPRESSED BONE TURNOVER; MICRODAMAGE ACCUMULATION; ALENDRONATE; MINERALIZATION; FEATURES;
D O I
10.1016/j.carj.2014.01.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This article provides an overview of atypical femoral fractures with a highlight on their radiographic findings. Potent antiresorptive agents such as bisphosphonates or denosumab have been associated with the development of such fractures. However, at this time, a causal association has not been conclusively established. Atypical femoral fractures are insufficiency fractures, which frequently present with bone pain. Early identification of characteristic radiographic features and withdrawal of antiresorptive therapy may prevent the development of completed atypical femoral fractures. (C) 2015 Canadian Association of Radiologists. All rights reserved.
引用
收藏
页码:102 / 107
页数:6
相关论文
共 19 条
[1]   Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment [J].
Allen, Matthew R. ;
Reinwald, Susan ;
Burr, David B. .
CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (05) :354-360
[2]   Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment [J].
Allen, Matthew R. ;
Burr, David B. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (11) :1759-1765
[3]   Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate [J].
Allen, Matthew R. ;
Iwata, Ken ;
Phipps, Roger ;
Burr, David B. .
BONE, 2006, 39 (04) :872-879
[4]   RETRACTED: Atypical incomplete femoral fractures in asymptomatic patients on long term bisphosphonate therapy (Retracted Article) [J].
Allison, M. B. ;
Markman, L. ;
Rosenberg, Z. ;
Vieira, R. L. ;
Babb, J. ;
Tejwani, N. ;
Peck, V. .
BONE, 2013, 55 (01) :113-118
[5]   Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis [J].
Armamento-Villareal, Reina ;
Napoli, Nicola ;
Panwar, Vinita ;
Novack, Deborah .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19) :2048-2050
[6]   Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women [J].
Boivin, GY ;
Chavassieux, PM ;
Santora, AC ;
Yates, J ;
Meunier, PJ .
BONE, 2000, 27 (05) :687-694
[7]   Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats [J].
Cao, YP ;
Mori, S ;
Mashiba, T ;
Westmore, MS ;
Ma, L ;
Sato, M ;
Akiyama, T ;
Shi, LP ;
Komatsubara, S ;
Miyamoto, K ;
Norimatsu, H .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (12) :2237-2246
[8]   Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features [J].
Giusti, Andrea ;
Hamdy, Neveen A. T. ;
Dekkers, Olaf M. ;
Ramautar, Sharita R. ;
Dijkstra, Sander ;
Papapoulos, Socrates E. .
BONE, 2011, 48 (05) :966-971
[9]  
IWATA K, 2006, BONE S, V38, P42
[10]  
MacDonald MM, 2007, BONEKEY, V4, P236